NASDAQ:CSII Cardiovascular Systems (CSII) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CSII Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$20.00▼$20.0050-Day Range$19.87▼$20.0052-Week Range$12.26▼$20.57Volume4,300 shsAverage Volume765,906 shsMarket Capitalization$843.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cardiovascular Systems alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Cardiovascular Systems Stock (NASDAQ:CSII)Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. CSII Stock News HeadlinesApril 24, 2024 | msn.comArtificial intelligence can evaluate cardiovascular risk during CT scanApril 22, 2024 | msn.comClimate change predicted to spike cardiovascular deaths in ChinaMay 5, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. April 19, 2024 | money.usnews.comCardiovascular Technologist SalaryApril 13, 2024 | msn.comPatient-centered cardiovascular care enhances outcomesApril 11, 2024 | msn.comCardiovascular care centered on the patient is key and helps improve equity and outcomes, say expertsApril 9, 2024 | msn.comA Transformational Advance in Medicine: Meridian Cardiovascular Systems Redefines the Treatment of Cardiovascular Disease and BeyondApril 3, 2024 | msn.comNew research links social factors to cardiovascular risk in Asian American adultsMay 5, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. March 25, 2024 | msn.comSulpizio Cardiovascular Center Installs Advanced PacemakerMarch 14, 2024 | msn.comCardiologists lead national study on novel bleeding monitoring systemMarch 14, 2024 | msn.comPilot program for virtual cardiac rehab expands to new hospitalsMarch 6, 2024 | msn.comIncreased daily step count may reduce the risk of death and cardiovascular diseaseMarch 6, 2024 | msn.comA daily step count goal may counteract the effects of sitting all day, study findsFebruary 28, 2024 | msn.comMenu calorie labeling may reduce deaths from cardiovascular disease in England, modeling study suggestsFebruary 15, 2024 | tmcnet.comPINC AI™ and Fortune Name the Nation's 50 Top Cardiovascular Hospitals™February 12, 2024 | msn.comA century of progress in the fight against cardiovascular diseaseFebruary 7, 2024 | msn.comHeart-brain axis dysfunction: Sports-related concussions can alter cardiovascular functionFebruary 7, 2024 | tmcnet.comCardiology Information Systems: Enhancing Cardiovascular Care and Driving Market Growth to US$ 3.4 Billion by 2034January 22, 2024 | msn.comNew Research Shows How Resistance Training May Help Reduce Cardiovascular Disease RiskJanuary 22, 2024 | msn.comEmergency cardiovascular care impact goal outlines three target needsJanuary 2, 2024 | msn.comThe 4 New Year's Resolutions Cardiologists Always MakeDecember 26, 2023 | msn.comDid You Know That Cardio Uses 3 Different Energy Systems? Here’s How To Shape Your Workout To Maximize the Benefits of EachDecember 14, 2023 | msn.comEating meals early could reduce cardiovascular riskDecember 12, 2023 | markets.businessinsider.comMyCardiologist Revolutionizes Heart Health Assessment & Cardiac Event Reduction with Cutting-Edge Cardiac PET ImagingDecember 2, 2023 | msn.comCardiovascular diseases: Expert explains why they occurSeptember 23, 2023 | msn.comStress a key factor in cardiovascular disease, a top cause of mortality across SASee More Headlines Receive CSII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2023Today5/04/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CSII CUSIP14161910 CIK1180145 Webwww.csi360.com Phone(651) 259-1600Fax612-677-3355Employees780Year Founded1989Profitability EPS (Most Recent Fiscal Year)($0.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,930,000.00 Net Margins-15.79% Pretax Margin-15.73% Return on Equity-15.39% Return on Assets-11.93% Debt Debt-to-Equity Ratio0.08 Current Ratio6.04 Quick Ratio4.92 Sales & Book Value Annual Sales$239.84 million Price / Sales3.52 Cash FlowN/A Price / Cash FlowN/A Book Value$6.12 per share Price / Book3.27Miscellaneous Outstanding Shares42,198,000Free Float40,594,000Market Cap$843.96 million OptionableOptionable Beta0.74 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesScott R. WardChairman, President & Chief Executive OfficerJohn M. HastingsExecutive Vice President-Operations & TechnologyJeffrey S. PointsChief Financial OfficerJeffery W. ChambersChief Medical OfficerAndrew P. O'BrienVice President-Information TechnologyKey CompetitorsAtriCureNASDAQ:ATRCOrthofix MedicalNASDAQ:OFIXSurmodicsNASDAQ:SRDXInovio PharmaceuticalsNASDAQ:INOAngioDynamicsNASDAQ:ANGOView All Competitors CSII Stock Analysis - Frequently Asked Questions How were Cardiovascular Systems' earnings last quarter? Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to analyst estimates of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted ($0.23) earnings per share. What is Scott Ward's approval rating as Cardiovascular Systems' CEO? 35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend. What other stocks do shareholders of Cardiovascular Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG). This page (NASDAQ:CSII) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiovascular Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
